British actor Tom Taylor has recently managed to make headlines as the actor has been cast for the coveted role of Cregan Stark in the critically acclaimed show, House of the Dragon. While no official date for the second season's premiere has been announced yet, the show is rumored to arrive sometime in early 2024.
The prequel to Game of Thrones, House of the Dragon is set 200 years before the events of the television series and relates the tale of the Dance of the Dragons, a civil war that tore House Targaryen apart.
Viserys I of Targaryen is seated at the helm at the start of the program. Although he is a kind and respected man, he is not a powerful leader. Additionally, he lacks clarity and is readily swayed by his advisers. When Viserys dies, his son Aegon and daughter Rhaenyra each claim the throne, causing a succession crisis. The conflict between the two factions splits the Seven Kingdoms.
A narrative about ambition, betrayal, and interpersonal struggle is found in House of the Dragon. The show has received accolades for its breathtaking visuals, intricate characters, and political intrigue.
House of the Dragon's Tom Taylor has starred in a host of acclaimed projects
Tom Taylor, an actor known for his versatility, has taken on a range of characters, whether it be in historical dramas, science fiction films, or thrillers.
At a young age, Taylor started his acting career by participating in community plays and school shows. His first professional role was in the 2015 BBC series The Last Kingdom. He portrayed the role of a young Uhtred of Bebbanburg. Taylor received recognition for his maturity and presence on film, as well as for his critically lauded performance.
Taylor made an appearance in the 2017 season of Doctor Who on the BBC. He portrayed the Doctor's companion, Harry Sullivan, in the performance. Critics once again praised Taylor's performance, praising him for his comic timing and chemistry with Peter Capaldi, his co-star.
He has also made appearances in a variety of movies, such as Close to Me in 2021 and The Dark Tower in 2017. The actor delivered eloquent and complex performances in both movies.
The actor is certainly a gifted performer who has a promising future and will undoubtedly rank among Hollywood's biggest stars in the years to come.
Who is Cregan Stark in House of the Dragon season 2?
A significant player in the Dance of the Dragon, the conflict that splits House Targaryen, is Cregan Stark, often known as the Wolf of the North. Although he is only a young man, he is already a fierce warrior and a cunning politician. The legitimate successor to the Iron Throne, Rhaenyra Targaryen, has the steadfast backing of Cregan.
In the Dance of the Dragons in the second season of House of the Dragon, Cregan Stark will play a crucial role. He will be essential in determining how the war will turn out as he leads the North into combat against Aegon II Targaryen's armies.
Cregan Stark is a fascinating and intriguing person. Although he is a terrible warrior, he is also a just and upright figure. A fierce adversary as well as a devoted friend, he is sure to be one of the most captivating characters in House of the Dragon's second season.
House of the Dragon season 2 is rumored to arrive in early 2024.
More from Sportskeeda
" modalPopup.closeOnEsc = false; modalPopup.setHeader("Why did you not like this content?"); modalPopup.setContentText(modalText); modalPopup.addCancelOkButton("Submit", resetRatingAndFeedbackForm, sendRating); modalPopup.removeCloseModalIcon(); modalPopup.disableDismissPopup(); modalPopup.open(); } else { sendRating(index); } } function sendRating() { var requestPayload = { "post_id": 1682570, "rating_value": ratingValue } if (ratingValue > 3) { requestPayload.rating_feedback_type = null; requestPayload.rating_feedback = null; } else { if (!$('input[name="drone"]:checked') || !$('input[name="drone"]:checked').value) { showErrorMessage('option'); return; } if (!$(".post-rating-feedback-note textarea") || !$(".post-rating-feedback-note textarea").value) { showErrorMessage('note'); return; } var selectedOption = $('input[name="drone"]:checked').value; var feedbackNote = $(".post-rating-feedback-note textarea").value; requestPayload.rating_feedback_type = selectedOption; requestPayload.rating_feedback = feedbackNote; } pureJSAjaxPost(addratingAPI, requestPayload, onsaveRatingSuccess, onsaveRatingFail, function() {}, true); } function resetRatingAndFeedbackForm() { var activeStars = Array.from($all('.rating span.rating-star.active')); for (var i=0; i < activeStars.length; i++) { activeStars[i].classList.remove("active"); } if ($('input[name="drone"]:checked')) { $('input[name="drone"]:checked').checked = false; } var userNote = document.querySelector(".post-rating-feedback-note textarea"); userNote.value = ''; modalPopup.close(); } function onsaveRatingSuccess() { modalPopup.close(); savePostIdInUserRatedPostsCookie(); $("#post-rating-layout").classList.add("hidden"); $("#post-rating-message").classList.remove("hidden"); window.setInterval(function showMessage() { $("#post-rating-widget").classList.add("hidden"); }, 3000); } function onsaveRatingFail() { console.error('Saving post rating failed!'); modalPopup.close(); } function savePostIdInUserRatedPostsCookie() { userRatedPostIds.push(1682570); var expiryTime = new Date(); expiryTime.setMonth(expiryTime.getMonth() + 12); // Expiry after 1 year setCookie("user_rated_post_ids", JSON.stringify(userRatedPostIds), expiryTime); } function isPostRatedByUser() { var userRatedPostIds = getCookie('user_rated_post_ids'); if (userRatedPostIds) { try { userRatedPostIds = JSON.parse(userRatedPostIds); } catch (err) { console.error(err); return false; } } else { return false; } if(userRatedPostIds.indexOf(1682570) >= 0) { return true; } else { return false; } } function getRatingCountByPostId(postId) { return new Promise(function(resolve, reject) { pureJSAjaxGet( getRatingCountBaseURL + postId + '/rating/count', function(data) { try { data = JSON.parse(data); if (data.meta_value) { resolve(data.meta_value); } reject("Failed to fetch rating count for the post:" + postId); } catch (err) { reject("Failed to fetch rating count for the post:" + postId); } }, function(err) { reject("Failed to fetch rating count for the post:" + postId); }, true); }); } function showErrorMessage(messageType) { var messageContainerId = '#' + messageType + '-error'; $(messageContainerId).classList.remove('hidden'); window.setInterval(function () { $(messageContainerId).classList.add("hidden"); }, 5000); } (function() { var callFired = false; function lazyLoadPostRating() { if (callFired) return; callFired = true; if (!isPostRatedByUser()) { getRatingCountByPostId(1682570) .then(function(ratingCount) { if (ratingCount < 10) { $("#post-rating-widget").classList.remove("hidden"); } }) .catch(function(err){ console.error(err); }); } } document.addEventListener("scroll", lazyLoadPostRating, { passive: true, once: true }); document.addEventListener("mousemove", lazyLoadPostRating, { passive: true, once: true }); document.addEventListener("touchmove", lazyLoadPostRating, { passive: true, once: true }); })();ncG1vNJzZmivp6x7tLzOq6uso5WasaJ6wqikaKifpXqkwcutrKudX6KypsCMraamZaSWxq270Waaq52Xlrtuv9OaqaRlmKTCtLGMrZ%2BeZZSnrqi7zaxkrJ2RqLyveZE%3D